Insights

Vulnerable Customer CoMentis specializes in clinical reg tech for identifying and supporting vulnerable customers in financial services, presenting a sales opportunity to partner with retirement and mortgage advisory firms seeking regulatory-compliant vulnerability tools.

Regulatory Tech Growth Strong interest from financial services partners (Just Group, HUB Group, Simply Biz Mortgages, Pensionhelp) indicates a growing market need for analytics and digital tools to assess mental capacity and vulnerability, ripe for expanding CoMentis’ regulatory technology offerings.

Channel Partnerships Existing collaborations with advisory networks suggest a go-to-market approach that leverages distribution through industry partners; consider formalizing reseller agreements or co-marketing programs with similar financial services distributors.

Expansion Potential With a footprint in mental capacity assessment and estate planning integration (Arken, will-writing software), there is opportunity to broaden penetration into private client and probate law markets, aligning with providers seeking robust vulnerability workflows.

Funding & Scale Current revenue range and substantial funding indicate capacity to scale; target mid-market financial advisory firms and smaller fintechs that need scalable, compliant vulnerability analytics rather than bespoke solutions.

Similar companies to CoMentis, Inc.

CoMentis, Inc. Tech Stack

CoMentis, Inc. uses 8 technology products and services including Cloudflare CDN, Cloudflare, Open Graph, and more. Explore CoMentis, Inc.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Open Graph
    Content Management System
  • Content Management System
  • Cookie Compliance
  • Hammer.js
    Javascript Libraries
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks

Media & News

CoMentis, Inc.'s Email Address Formats

CoMentis, Inc. uses at least 1 email format:
CoMentis, Inc. Email FormatsExamplePercentage
FLast@comentis.comJDoe@comentis.com
100%

Frequently Asked Questions

What is CoMentis, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
CoMentis, Inc.'s official website is comentis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does CoMentis, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, CoMentis, Inc.'s annual revenue is estimated to be $10M - $25M.

What is CoMentis, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
CoMentis, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CoMentis, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, CoMentis, Inc. has approximately 21 employees across 3 continents, including North America, Europe and Asia. Key team members include Chief Scientific Officer: M. T., Vice President Corporate Finance: G. M. and Member Of Scientific Advisory Board: E. C. Explore CoMentis, Inc.'s employee directory with LeadIQ.

What industry does CoMentis, Inc. belong to?

Minus sign iconPlus sign icon
CoMentis, Inc. operates in the Biotechnology Research industry.

What technology does CoMentis, Inc. use?

Minus sign iconPlus sign icon
CoMentis, Inc.'s tech stack includes Cloudflare CDN, Cloudflare, Open Graph, WordPress, CookieYes, Hammer.js, reCAPTCHA and Bootstrap.

What is CoMentis, Inc.'s email format?

Minus sign iconPlus sign icon
CoMentis, Inc.'s email format typically follows the pattern of FLast@comentis.com. Find more CoMentis, Inc. email formats with LeadIQ.

How much funding has CoMentis, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, CoMentis, Inc. has raised $108M in funding. The last funding round occurred on Apr 19, 2016 for $4.5M.

When was CoMentis, Inc. founded?

Minus sign iconPlus sign icon
CoMentis, Inc. was founded in 2006.
CoMentis, Inc. logo

CoMentis, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

CoMentis, Inc. is a biotechnology research company focused on discovering and developing small-molecule drugs aimed at central nervous system disorders. Located in South San Francisco, California, the firm operates within a specialized field that seeks to address neurological and related conditions through drug development. The company partners with advisory and clinical regulation technology providers to support vulnerable or at-risk client populations, reflecting its engagement with tools that assist professionals in managing care processes. CoMentis’ activities appear to center on leveraging scientific research to advance treatment options, with a business footprint that includes collaboration and technology integration across related service sectors. The organization is based in the San Francisco Bay Area and maintains a presence in the biotechnology ecosystem there.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $108M

    CoMentis, Inc. has raised a total of $108M of funding over 5 rounds. Their latest funding round was raised on Apr 19, 2016 in the amount of $4.5M as a Series E.

  • $10M - $25M

    CoMentis, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.